博力威(688345.SH):子公司廠區內的實驗室及辦公室等所在建築發生着火事故
格隆匯7月20日丨博力威(688345.SH)公吿,公司全資子公司東莞凱德新能源有限公司位於廣東省東莞市石排鎮,2021年7月20日上午3時50分左右,其廠區內的實驗室及辦公室等所在建築發生着火事故,明火已及時撲滅,事故現場得到有效控制,未造成人員傷亡,具體着火原因與損失正在調查之中。
據悉,着火事故發生後,公司已成立事件調查組並進駐現場開展調查工作,相關工作正在有序開展。
公司及子公司管理層將全力配合相關部門對本次事故進行調查及善後處理工作,並認真吸取此次着火事故教訓,進一步加強公司安全管理,制定整改措施和進一步消除可能存在的安全隱患,杜絕類似事件再次發生。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.